Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
OKYO Pharma Limited Sponsored ADR (OKYO) Weighted-Average Shares Outstanding (Diluted) data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.83M |
|
$0.00M |
|
$0.00M |
|
$2.83M |
|
$10.05M |
|
-- |
|
-- |
|
$10.05M |
|
$-7.23M |
|
$-7.23M |
|
$-7.23M |
|
33.94M |
|
| Cash Flow Statement Financials | |
$-0.24M |
|
-- |
|
$0.55M |
|
$0.83M |
|
$0.99M |
|
$0.16M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|